Association of Neonatal Jaundice with Gut Dysbiosis Characterized by Decreased Bifidobacteriales.

16S rRNA gene sequencing Bifidobacteriales bilirubin microbiota neonatal jaundice

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
18 Dec 2021
Historique:
received: 03 12 2021
accepted: 15 12 2021
entrez: 23 12 2021
pubmed: 24 12 2021
medline: 24 12 2021
Statut: epublish

Résumé

Neonatal jaundice, caused by excess serum bilirubin levels, is a common condition in neonates. Imbalance in the gut microbiota is believed to play a role in the development of neonatal jaundice. Thus, we aimed to reveal the gut microbiota characteristics in neonates with jaundice. 16S rRNA gene sequencing was performed on stool samples collected on day 4 from 26 neonates with jaundice (serum total bilirubin > 15.0 mg/dL) and 17 neonates without jaundice (total serum bilirubin < 10.0 mg/dL). All neonates were born full term, with normal weight, by vaginal delivery, and were breastfed. Neonates who were administered antibiotics, had serum direct bilirubin levels above 1 mg/dL, or had conditions possibly leading to hemolytic anemia were excluded. The median serum bilirubin was 16.0 mg/dL (interquartile range: 15.5-16.8) and 7.4 mg/dL (interquartile range: 6.8-8.3) for the jaundice and non-jaundice groups, respectively. There was no difference in the alpha diversity indices. Meanwhile, in the jaundice group, linear discriminant analysis effect size revealed that Bifidobacteriales were decreased at the order level, while Enterococcaceae were increased and Bifidobacteriaceae were decreased at the family level. Bifidobacteriaceae may act preventatively because of their suppressive effect on beta-glucuronidase, leading to accelerated deconjugation of conjugated bilirubin in the intestine. In summary, neonates with jaundice had dysbiosis characterized by a decreased abundance of Bifidobacteriales.

Identifiants

pubmed: 34940645
pii: metabo11120887
doi: 10.3390/metabo11120887
pmc: PMC8705620
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : "Private University Research Branding Project on intractable immune and allergic diseases" from Kansai Medical University
ID : n/a
Organisme : "research grant D1" from Kansai Medical University
ID : n/a

Références

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1291-1295
pubmed: 30779098
PLoS Pathog. 2013;9(7):e1003507
pubmed: 23935485
Turk J Med Sci. 2021 Aug 4;:
pubmed: 34344142
Front Microbiol. 2018 Jun 29;9:1417
pubmed: 30008707
Allergy. 2019 Jan;74(1):176-185
pubmed: 29786876
Lipids Health Dis. 2011 Jul 12;10:116
pubmed: 21745411
Afr J Prim Health Care Fam Med. 2018 Apr 12;10(1):e1-e6
pubmed: 29781686
J Nutr Biochem. 2019 Jan;63:54-61
pubmed: 30342317
Nature. 2019 Oct;574(7776):117-121
pubmed: 31534227
Nat Med. 2016 Oct;22(10):1187-1191
pubmed: 27618652
Am J Perinatol. 2020 Nov;37(13):1357-1363
pubmed: 31365932
Front Pediatr. 2020 May 12;8:177
pubmed: 32478013
Lancet Child Adolesc Health. 2018 Aug;2(8):610-620
pubmed: 30119720
Allergy. 2021 Jul;76(7):2279-2282
pubmed: 33650199
Scand J Gastroenterol. 1988 Jan;23(1):83-90
pubmed: 3344403
Pediatrics. 2018 Oct;142(4):
pubmed: 30209075
J Pediatr. 2013 Mar;162(3):477-482.e1
pubmed: 23043681
Am J Epidemiol. 2013 Dec 15;178(12):1691-7
pubmed: 24186969
BMJ Paediatr Open. 2017 Nov 25;1(1):e000105
pubmed: 29637134
Allergy. 2018 Jul;73(7):1515-1524
pubmed: 29318631
J Clin Invest. 2011 Jun;121(6):2126-32
pubmed: 21633181
Acta Diabetol. 2012 Feb;49(1):83-7
pubmed: 21984049
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Pediatr Allergy Immunol. 2021 May;32(4):690-701
pubmed: 33475191
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Ann Nutr Metab. 2019;74(2):132-139
pubmed: 30716730
Open Life Sci. 2018 Jun 07;13:208-216
pubmed: 33817085
Iran J Public Health. 2016 May;45(5):558-68
pubmed: 27398328
Sci Rep. 2017 Aug 30;7(1):10097
pubmed: 28855672
Cell. 2013 Dec 19;155(7):1451-63
pubmed: 24315484

Auteurs

Shohei Akagawa (S)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Yuko Akagawa (Y)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Sohsaku Yamanouchi (S)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Yoshiki Teramoto (Y)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Masahiro Yasuda (M)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Sadayuki Fujishiro (S)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Jiro Kino (J)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Masato Hirabayashi (M)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Kenji Mine (K)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Takahisa Kimata (T)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Masaki Hashiyada (M)

Department of Legal Medicine, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Atsushi Akane (A)

Department of Legal Medicine, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Shoji Tsuji (S)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Kazunari Kaneko (K)

Department of Pediatrics, Kansai Medical University, Hirakata-shi, Osaka 573-1010, Japan.

Classifications MeSH